Daniel Joseph Apel Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Daniel Joseph Apel is Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 176,200 shares of ARWR, which is worth approximately $7.27 Million. The most recent transaction as insider was on Jan 06, 2026, when has been sold 75,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 176K
n/a 3M change
n/a 12M change
Total Value Held $7.27 Million

Daniel Joseph Apel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
BUY
Grant, award, or other acquisition
-
75,000 Added 29.86%
176,200 Common Stock
DJA

Daniel Joseph Apel

Chief Financial Officer
Pasadena, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR